Literature DB >> 7577665

Complications of fourth-ventricular shunts.

M Lee1, D Leahu, H L Weiner, R Abbott, J H Wisoff, F J Epstein.   

Abstract

Fourth-ventricular shunting is commonly used to treat symptomatic posterior fossa cysts of the Dandy-Walker malformation and trapped fourth ventricle. Although the benefits of this procedure have been widely reported, there is a paucity of data on the pitfalls of posterior fossa shunting in the neurosurgical literature. During the 4-year period from July 1989 to June 1993, we placed fourth-ventricular shunts in 12 patients. Remarkably, 5 patients suffered complications related to posterior fossa catheter placement (42% rate). Three of these patients developed new cranial nerve dysfunction caused by direct injury to the floor of the fourth ventricle, 1 patient suffered an intracystic hemorrhage and acute shunt malfunction, and 1 patient had the catheter tip in the brainstem on postoperative studies without new neurological deficit. We conclude that placement of fourth-ventricular shunts can be fraught with complications which we believe is related to technique. We propose that altering the trajectory of the ventricular catheter from our usual midline technique to a more lateral position will lessen the chances for injury to the floor of the fourth ventricle. In this manner we hope to decrease our incidence of complications for this procedure.

Entities:  

Mesh:

Year:  1995        PMID: 7577665     DOI: 10.1159/000120921

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  15 in total

Review 1.  Management strategies for treatment of the trapped fourth ventricle.

Authors:  David H Harter
Journal:  Childs Nerv Syst       Date:  2004-07-15       Impact factor: 1.475

2.  Bilateral abducent and facial nerve palsies following fourth ventricle shunting: two case reports.

Authors:  Pietro Spennato; Donncha F O'Brien; John P Fraher; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2005-01-22       Impact factor: 1.475

3.  Endoscopic transaqueductal or interventricular stent placement for the treatment of isolated fourth ventricle and pre-isolated fourth ventricle.

Authors:  Hideki Ogiwara; Nobuhito Morota
Journal:  Childs Nerv Syst       Date:  2013-04-23       Impact factor: 1.475

4.  Cranial expansion and aqueductoplasty for combined isolated fourth ventricle and slit-ventricle syndrome: a surgical alternative.

Authors:  Jorge Tirado-Caballero; Mónica Rivero-Garvia; Gloria Moreno-Madueño; Emilio Gómez-González; Javier Márquez-Rivas
Journal:  Childs Nerv Syst       Date:  2020-10-25       Impact factor: 1.475

Review 5.  Hydrocephalus in Dandy-Walker malformation.

Authors:  Pietro Spennato; Giuseppe Mirone; Anna Nastro; Maria Consiglio Buonocore; Claudio Ruggiero; Vincenzo Trischitta; Ferdinando Aliberti; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

6.  Cranial nerve palsies after shunting of an isolated fourth ventricle.

Authors:  Alexandre Simonin; Marc Levivier; Jocelyne Bloch; Mahmoud Messerer
Journal:  BMJ Case Rep       Date:  2015-09-09

7.  Microsurgical outlet restoration in isolated fourth ventricular hydrocephalus: a single-institutional experience.

Authors:  Lena Armbruster; Mathias Kunz; Birgit Ertl-Wagner; Jörg-Christian Tonn; Aurelia Peraud
Journal:  Childs Nerv Syst       Date:  2012-08-16       Impact factor: 1.475

8.  Complications after shunting isolated IV ventricles.

Authors:  H G Eder; K A Leber; W Gruber
Journal:  Childs Nerv Syst       Date:  1997-01       Impact factor: 1.475

9.  Endoscopic aqueductoplasty: stent or not to stent?

Authors:  Michael J Fritsch; Sven Kienke; H Maximilian Mehdorn
Journal:  Childs Nerv Syst       Date:  2003-12-19       Impact factor: 1.475

10.  Unusual subacute diencephalic edema associated with a trapped fourth ventricle: resolution following foramen magnum decompression.

Authors:  Suhas Udayakumaran; Xiao Bo; Liat Ben Sira; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2009-06-16       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.